AI assistant
Elmos Semiconductor SE — Interim / Quarterly Report 2022
May 5, 2022
137_10-q_2022-05-05_fbaefb20-70f6-485d-8662-8f40a638f419.pdf
Interim / Quarterly Report
Open in viewerOpens in your device viewer
Quarterly statement Q1 2022
1
January 1 to March 31, 2022

Strong growth in Q1 – guidance for 2022 raised
Sales (96.4 million Euro) and EBIT margin (20.2%) up significantly year on year in Q1 2022
"We got off to a very successful start in fiscal year 2022 despite the major challenges posed by allocation, the ongoing effects of the pandemic, and the war in Ukraine. Demand for our innovative semiconductors remains strong and all our product segments are showing a dynamic development, as reflected in our full-year guidance. As an innovative semiconductor manufacturer, we will continue to sustainably benefit from the structural market growth and from the increasing electrification of all vehicle systems and functions in the future." Dr. Arne Schneider, CEO of Elmos Semiconductor SE
| in million Euro unless otherwise indicated | Q1 2022 | Q1 2021 | Change |
|---|---|---|---|
| Sales | 96.4 | 77.1 | 25.0% |
| Gross profit | 43.9 | 32.6 | 35.0% |
| in % of sales | 45.6% | 42.2% | |
| Research & development expenses | 13.6 | 12.3 | 11.1% |
| in % of sales | 14.1% | 15.9% | |
| Operating income before other operating expenses (-) / income | 21.2 | 11.3 | 88.0% |
| in % of sales | 22.0% | 14.6% | |
| EBIT | 19.5 | 12.2 | 59.8% |
| in % of sales | 20.2% | 15.8% | |
| Consolidated net income after non-controlling interests | 13.5 | 8.3 | 63.7% |
| in % of sales | 14.0% | 10.7% | |
| Earnings per share (basic) in Euro | 0.79 | 0.46 | 73.4% |
| 03/31/2022 12/31/2021 | Change | ||
| Total assets | 487.4 | 418.0 | 16.6% |
| Shareholders' equity | 313.2 | 300.2 | 4.4% |
| in % of total assets | 64.3% | 71.8% | |
| Financial liabilities | 95.1 | 76.1 | 25.0% |
| Liquid assets and securities | 114.1 | 66.1 | 72.6 |
| Net cash/net debt (-) | 19.0 | -10.0 | n/a |
| Q1 2022 | Q1 2021 | Change | |
| Operating cash flow | 43.9 | 29.4 | 49.2% |
| Capital expenditures | 11.1 | 5.7 | 93.8% |
| in % of sales | 11.5% | 7.4% | |
| Adjusted free cash flow | 30.4 | 22.4 | 35.8% |
Definitions of selected financial indicators
- Capital expenditures: Capital expenditures for intangible assets and property, plant and equipment less capitalized development expenses - Adjusted free cash flow: Cash flow from operating activities less capital expenditures for/plus disposal of intangible assets and property, plant and equipment (including proceeds from additions to the scope of consolidation)
Key figures Profit, financial position, as well as assets and liabilities
- -> The positive sales and earnings performance is the result of the consistently high demand for Elmos semiconductors in all product segments.
- -> Group sales were up significantly year on year and reflect the highest quarterly sales to date in the Company's history.
- -> As a result of the strong growth EBIT and EBIT margin were also higher than in the prior-year period – despite persistently high material prices as well as effects relating to the allocation and the pandemic.
- -> Capital expenditures in the first quarter of 2022 mainly relate to the planned expansion of test capacities.
- -> Adjusted free cash flow was well above the prior-year quarter despite the growth investments, mainly influenced by the high net result and by tax adjustments originating from our 2020 results.
- -> The ratio of orders on hand for the next three months to sales over the past three months, known as the book-to-bill ratio, was above one at the end of the reporting period.
Sales by region

Guidance update report
| Fiscal year 2022 | As of May 3, 2022 | As of February 15, 2022 |
|---|---|---|
| Sales | More than 400 million Euro | At least +15% to more than 370 million Euro |
| Operating EBIT margin | 21% ± 2 percentage points | 20% ± 2 percentage points |
| Capital expenditures (in % of sales)1 | 17% ± 2 percentage points | 16% ± 2 percentage points |
| Adjusted operating free cash flow2 | Positive, above the prior year (11.1 million Euro) |
Positive, above the prior year (11.1 million Euro) |
| Assumed exchange rate | 1.10 EUR/USD | 1.15 EUR/USD |
1 Capital expenditures for intangible assets and property, plant, and equipment less capitalized development expenses 2 Cash flow from operating activities less capital expenditures for/plus disposal of intangible assets and property, plant and equipment
Due to the current order situation and the available wafer capacities Elmos has raised its guidance for fiscal year 2022.
- -> Elmos now expects Group sales of more than 400 million Euro and an operating EBIT margin of 21% ± 2 percentage points of sales.
- -> The expansion of test capacities will be continued, with Elmos forecasting capital expenditures of around 17% ± 2 percentage points of sales.
- -> For fiscal year 2022, the company still expects to generate a positive operating adjusted free cash flow above the previous year (11.1 million Euro).
- -> The guidance does not include any effects from a possible closing of the sale of the Elmos wafer fab to Silex Microsystems AB.
- -> Expectations may be affected by market turbulence or global political and economic uncertainties, including the allocation in the semiconductor market, supply bottlenecks for key components, armed conflicts, as well as by the ongoing COVID-19 pandemic or similar.
Condensed consolidated statement of financial position
| Assets in thousand Euro | 03/31/2022 | 12/31/2021 |
|---|---|---|
| Intangible assets | 38,819 | 37,668 |
| Property, plant and equipment | 181,666 | 170,865 |
| Securities | 57,247 | 42,850 |
| Investments | 1 | 1 |
| Other financial assets | 8,398 | 8,379 |
| Deferred tax assets | 75 | 54 |
| Non-current assets | 286,206 | 259,817 |
| Inventories | 79,650 | 80,140 |
| Trade receivables | 46,480 | 39,745 |
| Securities | 4,519 | 5,492 |
| Other financial assets | 2,328 | 2,143 |
| Other receivables | 15,166 | 12,314 |
| Income tax assets | 672 | 599 |
| Cash and cash equivalents | 52,349 | 17,756 |
| Current assets | 201,165 | 158,190 |
| Total assets | 487,371 | 418,007 |
| Equity and liabilities in thousand Euro | 03/31/2022 | 12/31/2021 |
|---|---|---|
| Share capital | 17,700 | 17,700 |
| Treasury shares | -591 | -591 |
| Additional paid-in capital | 18,252 | 18,111 |
| Surplus reserve | 102 | 102 |
| Other equity components | -694 | -23 |
| Retained earnings | 277,707 | 264,146 |
| Equity attributable to owners of the parent | 312,477 | 299,445 |
| Non-controlling interests | 759 | 715 |
| Equity | 313,236 | 300,160 |
| Provisions for pensions | 52 | 52 |
| Financial liabilities | 78,250 | 61,527 |
| Deferred tax liabilities | 9,488 | 9,314 |
| Non-current liabilities | 87,790 | 70,894 |
| Provisions | 22,941 | 16,298 |
| Income tax liabilities | 11,874 | 246 |
| Financial liabilities | 16,865 | 14,581 |
| Trade payables | 30,846 | 12,071 |
| Other liabilities | 3,818 | 3,757 |
| Current liabilities | 86,345 | 46,954 |
| Liabilities | 174,135 | 117,847 |
| Total equity and liabilities | 487,371 | 418,007 |
| in thousand Euro | Q1 2022 | Q1 2021 |
|---|---|---|
| Sales | 96,359 | 77,106 |
| Cost of sales | -52,413 | -44,552 |
| Gross profit | 43,947 | 32,553 |
| Research and development expenses | -13,616 | -12,251 |
| Distribution expenses | -4,262 | -4,073 |
| Administrative expenses | -4,902 | -4,969 |
| Operating income before other operating expenses (-)/income | 21,166 | 11,261 |
| Foreign exchange gains | 921 | 1,076 |
| Other operating income | 582 | 585 |
| Other operating expenses | -3,200 | -735 |
| Earnings before interest and taxes (EBIT) | 19,470 | 12,188 |
| Finance income | 134 | 99 |
| Finance expenses | -330 | -223 |
| Earnings before taxes | 19,275 | 12,063 |
| Income tax | -5,694 | -3,746 |
| thereof current income tax | -5,094 | -3,100 |
| thereof deferred tax | -600 | -645 |
| Consolidated net income | 13,581 | 8,318 |
| thereof attributable to owners of the parent | 13,536 | 8,268 |
| thereof attributable to non-controlling interests | 45 | 50 |
| Earnings per share | Euro | Euro |
| Basic earnings per share | 0.79 | 0.46 |
| Fully diluted earnings per share | 0.79 | 0.46 |
Condensed consolidated income statement Condensed consolidated statement of cash flows
| in thousand Euro | Q1 2022 | Q1 2021 |
|---|---|---|
| Consolidated net income | 13,581 | 8,318 |
| Depreciation and amortization | 8,423 | 7,420 |
| Losses from disposal of assets | 2 | 57 |
| Financial result | 196 | 125 |
| Other non-cash expense | 600 | 645 |
| Current income tax | 5,094 | 3,100 |
| Expense for stock awards/share matching | 141 | 77 |
| Changes in pension provisions | 0 | 8 |
| Changes in net working capital: | ||
| Trade receivables | -6,735 | -5,337 |
| Inventories | 490 | 7,394 |
| Other assets | -3,037 | -2,347 |
| Trade payables | 11,952 | 4,684 |
| Other provisions and other liabilities | 6,704 | 4,361 |
| Income tax refunds | 6,461 | 873 |
| Interest paid | -77 | -39 |
| Interest received | 134 | 99 |
| Cash flow from operating activities | 43,929 | 29,438 |
| Capital expenditures for intangible assets | -2,602 | -1,339 |
| Capital expenditures for property, plant and equipment | -10,900 | -5,771 |
| Proceeds from additions to the scope of consolidation | 0 | 64 |
| Payments from disposal of non-current assets | 5 | 13 |
| Payments for (-)/disposal of securities | -14,710 | 498 |
| Payments for other financial assets | -19 | -513 |
| Cash flow from investing activities | -28,226 | -7,048 |
| Proceeds from financial liabilities to banks | 19,487 | 2,000 |
| Repayment of liabilities from installment purchase | -159 | -157 |
| Repayment of leasing liabilities | -346 | -548 |
| Repayment of other financial liabilities | -280 | 0 |
| Other changes | 23 | 8 |
| Cash flow from financing activities | 18,725 | 1,303 |
| Increase in cash and cash equivalents | 34,428 | 23,693 |
| Effect of exchange rate changes on cash and cash equivalents | 165 | 2 |
| Cash and cash equivalents at beginning of reporting period | 17,756 | 40,313 |
| Cash and cash equivalents at end of reporting period | 52,349 | 64,008 |
Financial calendar
| Fiscal year 2022 | |
|---|---|
| Quarterly results Q1/20221 | May 5, 2022 |
| Annual General Meeting | May 11, 2022 |
| Quarterly results Q2/20221 | August 2, 2022 |
| Quarterly results Q3/20221 | November 3, 2022 |
1 The German Securities Trading Act (Wertpapierhandelsgesetz) and the Market Abuse Regulation oblige issuers to announce any information that may have a substantial price impact immediately, irrespective of the financial calendar. Therefore, we cannot rule out having to announce key figures of quarterly and annual results ahead of the dates mentioned above. As we can never rule out changes of dates, we recommend checking them in advance on the website (www.elmos.com).
Contact
Ralf Hoppe | Investor Relations
Phone: + 49 (0) 231-75 49-7000 Fax: + 49 (0) 231-75 49-111 [email protected]
Elmos Semiconductor SE
Heinrich-Hertz-Straße 1 44227 Dortmund | Germany Phone: + 49 (0) 231-75 49-0 Fax: + 49 (0) 231-75 49-149 [email protected] | www.elmos.com
Notice
This document is a quarterly statement in accordance with Section 51a Rules and Regulations for the Frankfurter Wertpapierbörse (Börsenordnung für die Frankfurter Wertpapierbörse). For mathematical reasons, tables and references may contain rounding differences to the exact figures (currency units, percentages, etc.).
Forward-looking statements
This report contains forward-looking statements that are based on assumptions and estimates made by the Elmos management. Even though we assume the underlying expectations of our statements to be realistic, we cannot guarantee these expectations will prove right. The assumptions may carry risks and uncertainties, and as a result actual events may differ materially from the forward-looking statements. Among the factors that could cause such differences are changes in general economic and business conditions, fluctuations of exchange rates and interest rates, the introduction of competing products, lack of acceptance of new products, and changes in business strategy. Elmos neither intends nor assumes any obligation to update its statements with respect to future events.
This English translation is provided for convenience only. The German text shall be the sole legally binding version.